Keywords
Pregnancy
Risk factor based screening
2013 WHO GDM diagnostic criteria
Categories
How to Cite
Abstract
Implementation of the 2013WHO diagnostic criteria for Gestational Diabetes Mellitus (GDM), with lower threshold values required for the diagnosis of GDM, may be associated with further rise in the number of missed cases, especially among “low risk women”. This prospective study determined the proportions of women with GDM who were low risk. A hundred and seventeen pregnant women of gestational age 24-32weeks were screened with 50-g glucose challenge Test (GCT) and their GDM risk factor status noted. GCT positive women had 75-gOGTT, using 2013WHO GDM diagnostic criteria. The prevalence of GDM was 7.7% and about 55% of women with GDM had “low risk” status. There was no significant difference in the plasma glucose values of low risk and high risk women. With more than 50% of women with GDM being low risk, risk factor-based screening approach may be very unreliable in screening for GDM.
References
Katreddy MV, Pappachan JM, Taylor SE, Nevill AM, Indusekhar R, Nayak AU. Hemoglobin A1c in early postpartum screening of women with gestational diabetes. World J Diabetes. 2013;4(3):76-81. https://doi.org/10.4239/wjd.v4.i3.76
Orluwene C, OjuleJ. Disparity In Diagnosis Of Gestational Diabetes Mellitus Using 75g And 100g Glucose Load Tests Among Ante-Natal Attendees At Madonna University Teaching Hospital, Elele, Rivers State. IOSR J Pharm. 2013;3(9):1-6. [Accessed 2021 Feb 02]. Available from: http://www.iosrphr.org/papers/v3i9/A0390106.pdf
Gabbe SG, Graves CR. Management of diabetes mellitus complicating pregnancy. Obstet Gynecol. 2003 Oct;102(4):857-68. https://doi.org/10.1016/j.obstetgynecol.2003.07.001
Muche AA, Olayemi OO, Gete YK. Effects of gestational diabetes mellitus on risk of adverse maternal outcomes: a prospective cohort study in Northwest Ethiopia. BMC Pregnancy and Childbirth. 2020;20(1):73. https://doi.org 10.1186/s12884-020-2759-8
Group HSCR. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002. [Accessed 2021 Feb 02]. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa0707943
Sullivan SD, Umans JG, Ratner R. Gestational diabetes: implications for cardiovascular health. Curr Diab Rep. 2012;12(1):43–52. https://doi.org/10.1007/s11892-011-0238-3
Bellamy L, Casas J-P, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773–9. https://doi.org/10.1016/S0140-6736(09)60731-5
Khandelwa M. GDM: post parturm management to reduce long-term risks. Curr Diab Rep. Aug 2008;8(4):287-93 https://doi.org/10.1007/s11892-008-0051-9
Utz B, Kolsteren P, De Brouwere V. Screening for Gestational Diabetes Mellitus: Are Guidelines from High-Income Settings Applicable to Poorer Countries? Clin Diabetes. 2015;33(3):152-8. https://doi.org/10.2337/diaclin.33.3.152
Lowe LP, Metzger BE, Dyer AR, Lowe J, McCance DR, Lappin TRJ, et al. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Associations of maternal A1C and glucose with pregnancy outcomes. 2012;35(3):574-80. https://doi.org/10.2337/dc11-1687
World Health Organization. Diagnostic Criteria and Classification of HyperglycaemiaFirst Detected in Pregnancy. Geneva: WHO, 2013 Contract No.: WHO_NMH_MND_13.2_eng. [Accessed 2021 Feb 02]. Available from: https://apps.who.int/iris/bitstream/handle/10665/85975/WHO_NMH_MND_13.2_eng.pdf;jsessionid=5CA891E17BA741B76739680A226BB912?sequence=1
Trinder P. Determination of Blood glucose using an Oxidase-Peroxidase System with a Non-carcinogenic Chromogen. J Clin Pathol. 1969;22:158-61. https://doi.org/10.1136/jcp.22.2.158
Fawole AO, Ezeasor C, Bello FA, Roberts A, Awoyinka BS, Tongo O, et al. Effectiveness of a structured checklist of risk factors in identifying pregnant women at risk of gestational diabetes mellitus: A cross-sectional study. Niger J Clin Pract. 2014;17:495-501. [Accessed 2021 Feb 02]. Available from: https://www.njcponline.com/text.asp?2014/17/4/495/134051
Anzaku AS, Musa J. Prevalence and associated risk factors for gestational diabetes in Jos, North-central, Nigeria. Archives of gynecology and obstetrics. 2013;287(5):859-63. https://doi.org/10.1007/s00404-012-2649-z
Olagbuji BN, Atiba AS, Olofinbiyi BA, Akintayo AA, Awoleke JO, Ade-Ojo IP, et al. Prevalence of and risk factors for gestational diabetes using 1999, 2013 WHO and IADPSG criteria upon implementation of a universal one-step screening and diagnostic strategy in a sub-Saharan African population. European Journal of Obstetrics and Gynecology and Reproductive Biology.189:27-32. https://doi.org/10.1016/j.ejogrb.2015.02.030
Moses R, Griffiths R, Davis W. Gestational diabetes: do all women need to be tested? Aust N Z J Obstet Gynaecol. 1995;35(4):387-9. https://doi.org/10.1111/j.1479-828X.1995.tb02148.x
Kuti MA, Abbiyesuku FM, Akinlade KS, Akinosun OM, Adedapo KS, Adeleye JO, et al. Oral glucose tolerance testing outcomes among women at high risk for gestational diabetes mellitus. J Clin Pathol. 2011;64:718-21. https://doi.org/10.1136/jcp.2010.087098
Tan PC, Ling LP, Omar SZ. Screening for gestational diabetes at antenatal booking in a Malaysian university hospital: the role of risk factors and threshold value for the 50-g glucose challenge test. Aust N Z J Obstet Gynaecol. 2007 Jun;47(3):191-7. https://doi.org/10.1111/j.1479-828X.2007.00717.x
Buchanan TA, Xiang AH. Gestational diabetes mellitus. The Journal of clinical investigation. 2005;115(3):485-91. [Accessed 2021 Feb 02]. Available from: https://www.jci.org/articles/view/24531
Poyhonen-Alho MK, Teramo KA, Kaaja RJ, Hiilesmaa VK. 50gram oral glucose challenge test combined with risk factor-based screening for gestational diabetes. European journal of obstetrics, gynecology, and reproductive biology. 2005;121(1):34-7. https://doi.org/10.1016/j.ejogrb.2004.10.008
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2021 Olumodeji A et al.
